If you’ve been following Invictus MD Strategies Corp (OTCMKTS:IVITF) during the course of this latest incarnation of the “great green wave”, then you’ve probably been thinking, “when is this flower going to bloom?” Well, the answer, apparently, is “this week”. The stock has been doing well, but it hasn’t been seriously popping until the past couple days, when we have seen back to back monster moves totaling about 25% in gains.
To help push the story, the company just announced that its wholly-owned subsidiary, Acreage Pharms Ltd., has been granted conditional approval to become a registered supplier with the Saskatchewan Liquor and Gaming Authority once legislation is implemented on October 17, 2018. According to the release, “In the interim, and subject to any federal restrictions, Acreage Pharms is eligible to supply product to authorized provincial wholesalers and retailers in advance of October 17.”
Invictus MD Strategies Corp (OTCMKTS:IVITF) bills itself ostensibly as a company that targets small and mid-size companies with “proven brands, strong customer focus, and significant growth potential. We direct the strategy towards profitability and growth for each of our portfolio companies.”
Moreover, according to a basic description used by the company on several finance hubs, they assist their portfolio companies with “business process integration and by structuring and deploying proper capital to support sustained growth.”
That said, from what we could find, it appears this is now really a Canadian cannabis producer. The company’s recent announcement adds to this narrative significantly.
According to company materials tagged to recent press releases, “Invictus is a global cannabis company offering a selection of products under a wide range of lifestyle brands. Our integrated sales approach is defined by five pillars of distribution including medical, adult-use, international, Licensed Producer to Licensed Producer and retail stores. Invictus has partnered with business leaders to convey our corporate vision, including KISS music legend and business mogul Gene Simmons as our Chief Evangelist Officer, and global branding agency Authentic Brands Group. Invictus is expanding its cultivation footprint, with two cannabis production facilities fully licensed under ACMPR in Canada and a third awaiting approval, featuring 100,000 square feet of available grow space today with 200,000 expected by January 2019 and 1 million by end of 2019. The Company will earmark 50 per cent of production to the medical and recreational markets, respectively. To ensure consistency in quality and supply, Invictus maintains all aspects of the growing process through its subsidiary, Future Harvest Development Ltd., a high-quality Fertilizer and Nutrients manufacturer. Invictus drives sustainable long-term shareholder value through a diversified product portfolio with over 69 Health Canada approved strains and a multifaceted distribution strategy including medical, recreational, international and retail.”
Find out when $IVITF stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, the company just announced its wholly-owned subsidiary got its conditional approval to become a registered supplier with the Saskatchewan Liquor and Gaming Authority. In all, we’ve witnessed 53% added to share values of the name over the past month of action, but this action is running counter to the larger trend in the name.
In addition, the name has seen a growing influx of trading interest, with the stock’s recent average trading volume running just under 200% beyond what we have been seeing over the larger time frame.
“We are thrilled to become a registered supplier in Saskatchewan, our third provincial agreement behind British Columbia and Alberta,” said Dan Kriznic CEO and Chairman for Invictus. “We can feel the momentum building ahead of legalization on October 17, 2018 and are actively seeking agreements with additional provinces to help ensure governments across Canada have enough supply to meet consumer demand.”
At this time, carrying a capital value in the market of $163.11M, IVITF has a significant war chest ($15.2M) of cash on the books, which is balanced by about $1.2M in total current liabilities. IVITF is pulling in trailing 12-month revenues of $2.5M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 175.4%. We will update the story again soon as further details emerge. Sign-up for continuing coverage on shares of $IVITF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $IVITF, either long or short, and we have not been compensated for this article.